Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups.

Autor: West KA; Second Genome Inc., Brisbane, CA, USA., Yin X; Second Genome Inc., Brisbane, CA, USA., Rutherford EM; Second Genome Inc., Brisbane, CA, USA., Wee B; Second Genome Inc., Brisbane, CA, USA., Choi J; Second Genome Inc., Brisbane, CA, USA., Chrisman BS; Department of Bioengineering, Stanford University, Stanford, CA, USA., Dunlap KL; Departments of Pediatrics (Systems Medicine), Stanford University, Stanford, CA, USA., Hannibal RL; Second Genome Inc., Brisbane, CA, USA., Hartono W; Second Genome Inc., Brisbane, CA, USA., Lin M; Second Genome Inc., Brisbane, CA, USA., Raack E; Second Genome Inc., Brisbane, CA, USA., Sabino K; Second Genome Inc., Brisbane, CA, USA., Wu Y; Second Genome Inc., Brisbane, CA, USA.; Labii Inc., South San Francisco, CA, USA., Wall DP; Departments of Pediatrics (Systems Medicine), Stanford University, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.; Department of Psychiatry and Behavioral Sciences (By Courtesy), Stanford University, Stanford, CA, USA., David MM; Department of Microbiology, Oregon State University, Corvallis, OR, USA.; Department of Pharmaceutical Sciences, Oregon State University, Corvallis, OR, USA., Dabbagh K; Second Genome Inc., Brisbane, CA, USA., DeSantis TZ; Second Genome Inc., Brisbane, CA, USA. todd@secondgenome.com., Iwai S; Second Genome Inc., Brisbane, CA, USA.

Publikováno v: Scientific reports [Sci Rep] 2022 Oct 11; Vol. 12 (1), pp. 17034. Date of Electronic Publication: 2022 Oct 11.

Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study.

Autor: Song L; School of Nursing, University of North Carolina, Chapel Hill, NC, United States.; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States., Dunlap KL; School of Nursing, University of North Carolina, Chapel Hill, NC, United States., Tan X; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States., Chen RC; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States., Nielsen ME; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States., Rabenberg RL; University of North Carolina, Chapel Hill, NC, United States., Asafu-Adjei JK; School of Nursing, University of North Carolina, Chapel Hill, NC, United States., Koontz BF; School of Medicine, Duke University, Durham, NC, United States., Birken SA; University of North Carolina, Chapel Hill, NC, United States., Northouse LL; School of Nursing, University of Michigan, Ann Arbor, MI, United States., Mayer DK; School of Nursing, University of North Carolina, Chapel Hill, NC, United States.; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2018 Feb 26; Vol. 7 (2), pp. e51. Date of Electronic Publication: 2018 Feb 26.

Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia.

Autor: McGill CM; Department of Chemistry, University of Alaska-Anchorage, Anchorage, AK 99508 USA., Brown TJ; Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA 17033 USA., Cheng YY; Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA 17033 USA., Fisher LN; Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA 17033 USA., Shanmugavelandy SS; Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033 USA., Gustafson SJ; Department of Chemistry and Biochemistry, University of Alaska-Fairbanks, Fairbanks, AK 99775 USA.; Plants for Human Health Institute, North Carolina State University, North Carolina Research Campus, Kannapolis, NC 28081 USA., Dunlap KL; Department of Chemistry and Biochemistry, University of Alaska-Fairbanks, Fairbanks, AK 99775 USA., Lila MA; Plants for Human Health Institute, North Carolina State University, North Carolina Research Campus, Kannapolis, NC 28081 USA., Kester M; Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033 USA.; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908 USA., Toran PT; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824 USA., Claxton DF; Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA 17033 USA., Barth BM; Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA 17033 USA.; Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033 USA.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824 USA.

Publikováno v: International journal of biopharmaceutical sciences [Int J Biopharm Sci] 2018 Jan; Vol. 1 (1). Date of Electronic Publication: 2018 Jan 02.